dc.contributor.author | Sagliker, Y | |
dc.contributor.author | Balal, M | |
dc.contributor.author | Ozkaynak, PS | |
dc.contributor.author | Paydas, S | |
dc.contributor.author | Sagliker, C | |
dc.contributor.author | Sagliker, HS | |
dc.contributor.author | Dilaver, S | |
dc.date.accessioned | 2020-06-21T15:38:22Z | |
dc.date.available | 2020-06-21T15:38:22Z | |
dc.date.issued | 2004 | |
dc.identifier.issn | 0270-9295 | |
dc.identifier.issn | 1558-4488 | |
dc.identifier.uri | https://doi.org/10.1016/j.semnephrol.2004.06.021 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/21383 | |
dc.description | 3rd International Congress on Uremia Research -- SEP 17-20, 2003 -- Taormina, ITALY | en_US |
dc.description | ozkaya, ozan/0000-0002-0198-1221; | en_US |
dc.description | WOS: 000224707400014 | en_US |
dc.description | PubMed: 15490409 | en_US |
dc.description.abstract | … | en_US |
dc.description.sponsorship | ABBOTT Labs, Amgen Inc, Asani, Baxter, Bellco, Bieffe, Biolife, Braun, Carex, Edward Life Sci, Fresinios, Gambro, Genzyme Corporat, Golden Bilance, Helbio Italia, Hospal, Kinesis, Plasmon, Sigma Tau Italia | en_US |
dc.language.iso | eng | en_US |
dc.publisher | W B Saunders Co-Elsevier Inc | en_US |
dc.relation.isversionof | 10.1016/j.semnephrol.2004.06.021 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | chronic renal failure | en_US |
dc.subject | secondary hyperparathyroidism | en_US |
dc.subject | renal osteodystreophy | en_US |
dc.title | Sagliker syndrome: Uglifying human face appearance in late and severe secondary hyperparathyroidism in chronic renal failure | en_US |
dc.type | conferenceObject | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 24 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.startpage | 449 | en_US |
dc.identifier.endpage | 455 | en_US |
dc.relation.journal | Seminars in Nephrology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |